Is Contraceptive Self-injection Cost-effective Compared to Contraceptive Injections from Facility-Based health Workers? Evidence from Uganda

Date of Publication
2020

A study was performed to assess the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Uganda.

The conlcusion of the study was that under a societal perspective, self-injected DMPA-SC averted more pregnancies and cost less compared to health-worker-administered DMPA-IM. Under a health system perspective, self-injected DMPA-SC can be cost-effective relative to DMPA-IM when a lower-cost visual aid for client training is used.